May 20, 2015
Institutional Review Board, Hospital for Special Surgery
The safety of our participants is our top priority. The trial/study is approved and periodically reviewed by the Institutional Review Board (IRB), which includes doctors, administrators, ethicists, and members of the general public. The safety of clinical trials is reviewed by the U.S. Food and Drug Administration.
Before enrolling in a clinical trial or research study, the investigator will explain the purpose of the trial/study, its expected benefits, any possible risks or side effects, and what your role will be. If you want to join the trial/study, you must sign informed consent documents. You can leave a trial/study at any time without penalty.
For further information, see Understanding Clinical Trials/Research Studies.
Michael B. Cross, MD
Seth A. Jerabek, MD
Kaitlin M. Carroll, BS
Joseph Nguyen
Liz Niedbala
The study will begin when IRB approval is granted and will continue until 50 patients are recruited. Follow-up will be for 1 year after the indexed surgical intervention.
The study will begin when IRB approval is granted and will continue until 50 patients are recruited. Follow-up will be for 1 year after the indexed surgical intervention.
David J. Mayman MD
maymand@hss.edu
212.774.2024